Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-28 1:51 pm Sale |
2023-06-26 | 13D | CTI BioPharma Corp. CTIC |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-28,463,021 (Position Closed) |
Filing History |
| 2023-06-22 4:47 pm Purchase |
2023-06-12 | 13G | Delcath Systems, Inc. DCTH |
BIOTECHNOLOGY VALUE FUND L P | 1,561,514 9.990% |
1,561,514 (New Position) |
Filing History |
| 2023-06-05 4:45 pm Purchase |
2023-05-26 | 13G | TScan Therapeutics, Inc. TCRX |
BIOTECHNOLOGY VALUE FUND L P | 4,414,910 9.990% |
4,414,910 (New Position) |
Filing History |
| 2023-05-30 4:45 pm Purchase |
2023-05-17 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% |
4,106,945 (New Position) |
Filing History |
| 2023-05-22 4:47 pm Purchase |
2023-05-11 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 22.000% |
161,448 (+167.87%) |
Filing History |
| 2023-03-24 4:33 pm Purchase |
2023-03-14 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 2,455,089 5.100% |
250,000 (+11.34%) |
Filing History |
| 2023-03-20 5:04 pm Purchase |
2023-03-10 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 5,025,900 9.600% |
3,775,900 (+302.07%) |
Filing History |
| 2023-03-16 4:48 pm Purchase |
2023-03-06 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,360,941 5.000% |
84,398 (+2.58%) |
Filing History |
| 2023-03-06 5:10 pm Purchase |
2023-02-24 | 13G | ASLAN Pharmaceuticals Limited ASLN |
BIOTECHNOLOGY VALUE FUND L P | 1,061,000 9.990% |
1,061,000 (New Position) |
Filing History |
| 2023-02-14 12:10 pm Sale |
2022-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,510,072 12.600% |
-16,210 (-0.36%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 2,205,089 4.600% |
240,230 (+12.23%) |
Filing History |
| 2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD |
BIOTECHNOLOGY VALUE FUND L P | 9,665 6.900% |
-333 (-3.34%) |
Filing History |
| 2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.400% |
-1,156,651 (-27.97%) |
Filing History |
| 2023-02-14 12:00 pm Sale |
2022-12-31 | 13G | 89bio, Inc. ETNB |
BIOTECHNOLOGY VALUE FUND L P | 3,521,126 6.500% |
-376,874 (-9.67%) |
Filing History |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | POINT Biopharma Global Inc. PNT |
BIOTECHNOLOGY VALUE FUND L P | 9,177,748 8.700% |
3,587,700 (+64.18%) |
Filing History |
| 2023-02-14 11:58 am Sale |
2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BIOTECHNOLOGY VALUE FUND L P | 2,736,613 5.100% |
-267,266 (-8.90%) |
Filing History |
| 2023-02-14 11:58 am Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.200% |
-1,657,428 (-41.84%) |
Filing History |
| 2023-02-14 11:56 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-1,647,400 (Position Closed) |
Filing History |
| 2023-02-14 11:56 am Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BIOTECHNOLOGY VALUE FUND L P | 984,824 1.400% |
-2,129,708 (-68.38%) |
Filing History |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 7,509,059 16.400% |
2,139,600 (+39.85%) |
Filing History |